All In Biotech

NDA 021261 · Medtech Products

Monistat 3 Combination Pack

Miconazole Nitrate · Topical, Vaginal

Last checked: Nov 20, 2026Latest source record: Jul 22, 2020 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2001

Feb 2, 2001

Approved uses

1

Original approval plus efficacy supplements

Registered trials

36

8 Phase 3, 0 recruiting

FAERS reports

2,640

800 serious, 86 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Oct 27, 2025.

Uses treats vaginal yeast infections relieves external itching and irritation due to a vaginal yeast infection

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

2 products under this application
  • MONISTAT 3 COMBINATION PACK · MICONAZOLE NITRATE 2%,4% · CREAM, TOPICAL, VAGINAL · Over-the-counter
  • MONISTAT 3 COMBINATION PACK (PREFILLED) · MICONAZOLE NITRATE 2%,4% · CREAM, TOPICAL, VAGINAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Miconazole Nitrate" as an intervention, any sponsor and status, largest first.

All 36 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • vulvovaginal burning sensation742
  • vulvovaginal pain525
  • drug ineffective313
  • vulvovaginal pruritus253
  • vaginal haemorrhage235
  • vulvovaginal discomfort192
  • condition aggravated179
  • vulvovaginal swelling155
  • pain102
  • pruritus74
  • abdominal pain71
  • hypersensitivity69

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200414
200520
200620
200713
200836
200966
201042
201146
201273
201316
201423
201531
2016122
2017112
2018202
2019196
2020207
2021264
2022243
2023162
2024222
2025266
2026244

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 71 on PubMed

Sponsor: Medtech Products · Also marketed as Monistat 3 Combination Pack (Prefilled)

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.